228 related articles for article (PubMed ID: 30063110)
1. ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer.
Liu CY; Hsu CC; Huang TT; Lee CH; Chen JL; Yang SH; Jiang JK; Chen WS; Lee KD; Teng HW
Mol Oncol; 2018 Oct; 12(10):1706-1717. PubMed ID: 30063110
[TBL] [Abstract][Full Text] [Related]
2. CIP2A is a predictor of poor prognosis in colon cancer.
Teng HW; Yang SH; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Chen PC; Lan YT; Lin CC; Hsu YN; Wang HW; Chen KF
J Gastrointest Surg; 2012 May; 16(5):1037-47. PubMed ID: 22328001
[TBL] [Abstract][Full Text] [Related]
3. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
Liu CY; Huang TT; Chen YT; Chen JL; Chu PY; Huang CT; Wang WL; Lau KY; Dai MS; Shiau CW; Tseng LM
EBioMedicine; 2019 Feb; 40():263-275. PubMed ID: 30651219
[TBL] [Abstract][Full Text] [Related]
4. Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress.
Stengel ST; Fazio A; Lipinski S; Jahn MT; Aden K; Ito G; Wottawa F; Kuiper JWP; Coleman OI; Tran F; Bordoni D; Bernardes JP; Jentzsch M; Luzius A; Bierwirth S; Messner B; Henning A; Welz L; Kakavand N; Falk-Paulsen M; Imm S; Hinrichsen F; Zilbauer M; Schreiber S; Kaser A; Blumberg R; Haller D; Rosenstiel P
Gastroenterology; 2020 Oct; 159(4):1357-1374.e10. PubMed ID: 32673694
[TBL] [Abstract][Full Text] [Related]
5. CIP2A influences survival in colon cancer and is critical for maintaining Myc expression.
Wiegering A; Pfann C; Uthe FW; Otto C; Rycak L; Mäder U; Gasser M; Waaga-Gasser AM; Eilers M; Germer CT
PLoS One; 2013; 8(10):e75292. PubMed ID: 24098375
[TBL] [Abstract][Full Text] [Related]
6. Activating transcription factor 6 (ATF6) negatively regulates Polo-like kinase 4 expression via recruiting C/EBPβ to the upstream-promoter during ER stress.
Shen T; Li Y; Chen Z; Liang S; Qiu Y; Zhu L; Ba G; Lu G; Qiu L
Biochim Biophys Acta Gene Regul Mech; 2020 Feb; 1863(2):194488. PubMed ID: 31926341
[TBL] [Abstract][Full Text] [Related]
7. Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism.
Wang HW; Yang SH; Huang GD; Lin JK; Chen WS; Jiang JK; Lan YT; Lin CC; Hwang WL; Tzeng CH; Li AF; Yen CC; Teng HW
J Cancer Res Clin Oncol; 2014 Apr; 140(4):561-71. PubMed ID: 24493623
[TBL] [Abstract][Full Text] [Related]
8. ATF6 upregulates XBP1S and inhibits ER stress-mediated apoptosis in osteoarthritis cartilage.
Guo FJ; Xiong Z; Lu X; Ye M; Han X; Jiang R
Cell Signal; 2014 Feb; 26(2):332-42. PubMed ID: 24269637
[TBL] [Abstract][Full Text] [Related]
9. Sustained IRE1 and ATF6 signaling is important for survival of melanoma cells undergoing ER stress.
Tay KH; Luan Q; Croft A; Jiang CC; Jin L; Zhang XD; Tseng HY
Cell Signal; 2014 Feb; 26(2):287-94. PubMed ID: 24240056
[TBL] [Abstract][Full Text] [Related]
10. IL-10 promotes tumor aggressiveness via upregulation of CIP2A transcription in lung adenocarcinoma.
Sung WW; Wang YC; Lin PL; Cheng YW; Chen CY; Wu TC; Lee H
Clin Cancer Res; 2013 Aug; 19(15):4092-103. PubMed ID: 23743567
[TBL] [Abstract][Full Text] [Related]
11. Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells.
Zhao Q; Zhao M; Parris AB; Xing Y; Yang X
Int J Oncol; 2016 Sep; 49(3):1203-10. PubMed ID: 27574003
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer.
Birkman EM; Elzagheid A; Jokilehto T; Avoranta T; Korkeila E; Kulmala J; Syrjänen K; Westermarck J; Sundström J
Cancer Med; 2018 Mar; 7(3):698-706. PubMed ID: 29441695
[TBL] [Abstract][Full Text] [Related]
13. Role of CIP2A in the antitumor effect of bortezomib in colon cancer.
Ding Y; Wang Y; Ju S; Wu X; Zhu W; Shi F; Mao L
Mol Med Rep; 2014 Jul; 10(1):387-92. PubMed ID: 24789441
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CIP2A in clear cell renal cell carcinoma promotes cellular epithelial-mesenchymal transition and is associated with poor prognosis.
Tang Q; Wang Q; Zeng G; Li Q; Jiang T; Zhang Z; Zheng W; Wang K
Oncol Rep; 2015 Nov; 34(5):2515-22. PubMed ID: 26327467
[TBL] [Abstract][Full Text] [Related]
15. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.
Dong QZ; Wang Y; Dong XJ; Li ZX; Tang ZP; Cui QZ; Wang EH
Ann Surg Oncol; 2011 Mar; 18(3):857-65. PubMed ID: 20842459
[TBL] [Abstract][Full Text] [Related]
16. CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.
Khanna A; Rane JK; Kivinummi KK; Urbanucci A; Helenius MA; Tolonen TT; Saramäki OR; Latonen L; Manni V; Pimanda JE; Maitland NJ; Westermarck J; Visakorpi T
Oncotarget; 2015 Aug; 6(23):19661-70. PubMed ID: 25965834
[TBL] [Abstract][Full Text] [Related]
17. Quinocetone triggered ER stress-induced autophagy via ATF6/DAPK1-modulated mAtg9a trafficking.
Zhou Y; Zhang S; Dai C; Tang S; Yang X; Li D; Zhao K; Xiao X
Cell Biol Toxicol; 2016 Apr; 32(2):141-52. PubMed ID: 27085326
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases insulin gene expression via up-regulation of orphan nuclear receptor small heterodimer partner.
Seo HY; Kim YD; Lee KM; Min AK; Kim MK; Kim HS; Won KC; Park JY; Lee KU; Choi HS; Park KG; Lee IK
Endocrinology; 2008 Aug; 149(8):3832-41. PubMed ID: 18450959
[TBL] [Abstract][Full Text] [Related]
19. Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2A.
Chao TT; Wang CY; Chen YL; Lai CC; Chang FY; Tsai YT; Chao CH; Shiau CW; Huang YC; Yu CJ; Chen KF
Oncotarget; 2015 Feb; 6(4):2164-79. PubMed ID: 25537503
[TBL] [Abstract][Full Text] [Related]
20. ATF6 Decreases Myocardial Ischemia/Reperfusion Damage and Links ER Stress and Oxidative Stress Signaling Pathways in the Heart.
Jin JK; Blackwood EA; Azizi K; Thuerauf DJ; Fahem AG; Hofmann C; Kaufman RJ; Doroudgar S; Glembotski CC
Circ Res; 2017 Mar; 120(5):862-875. PubMed ID: 27932512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
